secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001493152-23-004481
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa Pharmaceuticals raises $6.25M in registered direct offering at $0.80/share
--------------------------------------------------------------------------------

- Sold 7,812,544 shares at $0.80/share; gross proceeds $6.25M, net ~$5.7M after fees.
- Closing expected Feb 14, 2023; Spartan Capital acted as sole placement agent.
- Proceeds to fund clinical trials, R&D, working capital, and general corporate purposes.
- Issuer subject to 90-day lockup until stock exceeds $2.00 for 10 consecutive trading days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223004481/0001493152-23-004481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223004481/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-004481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer